Sporadic ovarian cancer is a particularly aggressive tumor characterized by highly abnormal karyotypes exhibiting many features of genomic instability. More complex genomic changes in tumors arise as a consequence of chromosomal instability (CIN), which can generate both numerical [(N)-CIN] and structural chromosomal instability [(S)-CIN]. In this study, molecular cytogenetic analysis was used to evaluate the relative levels of both (N)-CIN and (S)-CIN. Six tumors had a near-diploid chromosome number, two were near-tetraploid, and two were near-triploid. (N)-CIN levels increased as a function of overall tumor genomic content, with near-diploid tumors exhibiting numerical instability indices ranging from 7.0 to 21.0 and near-tetraploid and triploid tumors exhibiting instability indices ranging from 24.9 to 54.9. In contrast, the extent of (S)-CIN was generally more evident in the diploid tumors compared with the near-tetraploid tumors. To determine whether the associated chromosomal constitution and/or ploidy changes were influenced by mitotic segregation errors, centrosome analyses were performed on all 10 tumors. The near-diploid tumors, with the lowest numerical change, were observed to possess fewer cells with centrosome abnormalities (5.5% to 14.0%), whereas the near-tetraploid tumors possessed much higher levels of (N)-CIN and were characterized by a trend of elevating percentages of cells with abnormal centrosomes (16.0% to 20.5%). These observations suggest that two distinct processes governing genome stability may be disrupted in ovarian cancer: those that impact on numerical segregation and ploidy of chromosomes and those that affect the fidelity of DNA repair and lead to structural aberrations.
Introduction
Ovarian cancer is the leading cause of death from a gynecological malignancy and the fourth leading cause of cancer death among North American women. The karyotypes of these tumors are characterized as aneuploid with complex chromosomal aberrations [1] [2] [3] [4] [5] . The features of many epithelial tumors, including ovarian cancer, are the presence of structural changes and aneuploidy, arising as a consequence of chromosomal instability (CIN) [6, 7] . CIN has been classically defined as the rate of whole chromosomal gains and losses [8, 9] and has been a useful means for assessing genomic heterogeneity. CIN has also been less frequently used to describe the presence of structural aberrations [7, 10] . More complex genomic changes in tumors arise as a consequence of CIN, which can generate both numerical [ 
(N)-CIN] and structural chromosomal instability [(S)-CIN].
The observed high levels of aneuploidy and structural complexity in these tumors suggest errors in DNA repair, mitotic segregation errors, and dysregulation of cell cycle checkpoints [11, 12] may generate (N)-CIN. However, the mechanisms that influence structural changes and gross aneuploidy are distinct. Structural rearrangements appear to be influenced by abnormal DNA repair pathways that result in errors in both homologous and nonhomologous end-joining of double-stranded DNA and may contribute to (S)-CIN [13] (reviewed in Bayani et al. [14] ). The formation of structural rearrangements may also come about through telomere-mediated events, where critically short telomeres are recognized as DNA breaks capable of recombining either homologously or nonhomologously when DNA-repair pathways are compromised and telomerase is activated [15] . In contrast to structural changes, aneuploidy arises through various mechanisms predominantly influenced by the dysregulation of cell cycle checkpoints and mitotic segregation errors [11, 16] .
Tetraploidy is a common feature of many carcinomas and sarcomas and is believed to be an initial stage in the development of aneuploidy, arising either through disruption of chromosome segregation during mitosis [17] or through failure of cytokinesis [18] . The tetraploidization event not only results in the doubling of genomic content, but also in the doubling of centrosomes [18, 19] . Aneuploidy can also arise from mechanisms independent of a tetraploid intermediate, suggesting that the components of the mitotic machinery possess aberrant function, such as the loss of centrosome duplication control, leading to abnormal centrosome amplification and creating multipolar spindles and unequal genomic segregation [20] .
Cytogenetic analyses of primary ovarian carcinomas have identified tumors with a range of numerical change, from near-diploid to highly aneuploid abnormal karyotypes. Moreover, within most reported studies, some tumors also have many chromosomes with a high degree of structural aberration, whereas others exhibited relatively few, simple rearrangements [1] [2] [3] [4] . Defining these varying characteristics in greater detail using primary ovarian cancer samples will provide insights concerning the mechanisms responsible for genomic diversity in these tumors. Recognition of such mechanisms associated with each class of chromosomal aberration will be beneficial in understanding the nature of karyotypic progression as well as opens avenues for future therapeutic strategies in ovarian carcinoma. Using integrative molecular cytogenetic analyses including spectral karyotyping (SKY), comparative genomic hybridization, and interphase fluorescence in situ hybridization (FISH), 10 sporadic primary ovarian cancer specimens derived from seven patients, previously described by our group [4] , were assessed for features of (N)-CIN and (S)-CIN in addition to centrosome amplification.
Materials and Methods

Patient Specimens and Cell Lines
Ten tumors from seven patients with sporadic ovarian cancer, and who gave informed consent, were obtained from The University Health Network, Toronto, during the years 2000-2001. All tumors, except for OCA27A/B and OCA714, were previously described by Bayani et al. [4] . These patients had no previous family history for ovarian or breast cancer, and all specimens were obtained at the first surgery before treatment. For three patients, two distinct tumor samples were obtained. OCA21A/OCA21B and OCA27A/OCA27B are paired primary/metastasis samples. For OCA15A/B, tumors were obtained from the right and left ovaries, respectively. A normal female control fibroblast (passage 9) was also maintained in culture and used as a technical control.
Peptide Nucleic Acid Fluorescence In Situ Hybridization and Spectral Karyotyping Analysis
Cell culture and chromosome preparation. Primary tissues were obtained at the time of surgery and promptly minced and treated with collagenase (Invitrogen, Burlington, Canada) for 24 hours at 37°C in a CO 2 incubator. The following day, the disaggregated tissue was processed for short-term culture and then prepared for cytogenetic harvest as previously described [4] . A normal control fibroblast culture was maintained and processed similarly.
Peptide Nucleic Acid Fluorescence In Situ Hybridization. For CIN studies, interphase FISH was performed using peptide nucleic acid (PNA) probes directly labeled with either fluorescein isothiocyanate or Rhodamine for centromeres 2, 4, 7, and 8 (Applied Biosystems, Foster City, CA). Pan-centromeric PNA probes (Applied Biosystems) were also used to identify the presence of multicentromeric chromosomes. The standard technique for PNA FISH was carried out as previously published by Wan et al. [21] . Two hundred nuclei were assessed in a coded fashion by two independent observers.
Generation of instability index. Each tumor specimen was assessed using all four PNA centromere probes. An instability index was generated based on published criteria by Lengauer et al. [8] . For each specimen, including a normal fibroblast, 200 nuclei were counted. The normal fibroblast sample served as a technical control for the overall hybridization efficiency for each centromere probe used and was found to be greater than 96% (Table W1) , with the average background noise across all centromere probes tested to be 3.6% [(2 + 3.5 + 4 + 4)/4)]. For the tumor specimens, the prevalent clones for each centromere probe tested were initially established by karyotypic (SKY) analysis, and the percentage of cells containing greater or less than that clonal population were enumerated. In keeping with guidelines of clonality [22] , if it was determined that the prevalent signal count for that centromere was not consistent with the karytoype analysis, the interphase FISH results were used in our analysis. Populations greater than 30% were identified and were considered as an additional clone and excluded from the enumeration. For example, in OCA3, the total percentage of cells possessing greater or less than four signals for centromere 2 was 52%; for centromere 4, the total percentage of cells possessing greater or less than two signals per cell was 24.5%; for centromere 7, the total percentage of cells possessing greater or less than four signals per cell was 37%; and for centromere 8, the total percentage of cells possessing greater or less than three signals per cell was 22%. Thus, the average CIN index is 33. Spectral karyotyping. SKY analysis was performed on metaphase preparations using the SKY Paints according to the manufacturer's instructions (Applied Spectral Imaging, Carlsbad, CA) and as described previously by Bayani et al. [4] . Karyotypes derived by SKY analysis reflect the clonal changes determined from at least 10 metaphase spreads where possible. A gain of a chromosome was described when identified in at least two metaphase spreads, a loss when identified in three or more cells, and a chromosomal rearrangement when identified in two or more cells. The karyotype descriptions were assigned according to the guidelines set forth by the International System for Cytogenetic Nomenclature (2005) [22] . Breakpoint enumeration was performed on intact metaphase spreads that were analyzable. Moreover, only clonal rearrangements were counted because the number of intact and analyzable spreads varied from sample to sample. In addition, duplicate rearrangements were only enumerated once.
Centrosome Immunostaining
For all cases, cells were grown on chambered glass slides and cultured to approximately 70% confluency. The cells were fixed with a 4% paraformaldehyde solution and processed for fluorescence immunohistochemistry with mouse monoclonal anti-γ-tubulin antibodies (Sigma-Aldrich, Oakville, Canada) as previously described [23] . Centrosome signals were evaluated in 200 nonoverlapping cells. For each specimen, the percentage of cells possessing greater than two centrosomes per cell were considered abnormal or if the signal size and shape were different from the size and shape in control cells [23, 24] . The slides were viewed and imaged using a Nikon Labophot-2 fluorescent microscope and analyzed using the Vysis Quips SmartCapture imaging system (Vysis, Downers Grove, Il).
Results
Numerical Chromosomal Instability
To determine (N)-CIN levels within the study group, interphase FISH was performed using centromere-specific probes from four representative chromosomes. Centromere probes for chromosomes 2, 4, 7, and 8 were chosen for this study based on their propensity for net gain (chromosomes 7 and 8), loss (chromosome 4), or tendency for little change (chromosome 2) as determined by previous cytogenetic and comparative genomic hybridization studies conducted by this group and others [1] [2] [3] [4] [5] . The raw scoring data are detailed in Table W1 . Table 1 summarizes the results of interphase CIN findings using the PNA probes, with representative images from OCA5, OCA 27B, and OCA714 in Figure 1 . An (N)-CIN index was generated for each tumor as described in Materials and Methods. Analysis based on the (N)-CIN indices revealed two distinct ranges of instability: those with a low (N)-CIN index ranging from 7.0 to 21.0, and another group of tumors with a higher (N)-CIN index ranging from 24.9 to 54.9. The copy number status of these tumors, as determined by previous SKY analysis [4] , revealed those cases with lower instability indices possessed karyotypes in the diploid or near-diploid range. This was in contrast to the second group where the instability indices were associated with triploid and tetraploid karyotypes. The tumor that showed the greatest instability was OCA5 ( Figure 1A ), a near-triploid tumor with an instability index of 54.9. The results of the individual chromosomes revealed a range of centromere signals from one to as many as nine signals per cell for the four chromosomes tested. OCA3 displayed the next greatest instability index of 33.9. Like OCA5, OCA3 was characterized as near-triploid; however, the range of instability was not as extensive as that of OCA5. Among the neartetraploid tumors, OCA27A/B, paired primary and metastatic tumors, possessed instability indices of 24.9 and 32.7, respectively, for which the FISH and SKY findings for OCA27B are illustrated in Figure 1B . OCA15A/B are pair samples showing similar instability indices of 10.7 and 12.7, respectively. Karyotype analysis revealed a hypodiploid karyotype with numerous structural aberrations similar to both specimens. OCA714 possessed an instability index of 7.0, showing a diploid karyotype as confirmed by SKY analysis ( Figure 1C ). When the (N)-CIN indices were plotted in ascending order (Figure 2 ), the resulting trend revealed that numerical instability increased in association with transitions in ploidy; specifically, there was very little instability among the more diploid tumors, whereas near-tetraploid tumors showed a moderate to high level of instability and near-triploid tumors showed the greatest level of instability.
Structural Chromosomal Instability
To determine (S)-CIN levels, the number of clonal breakpoints were enumerated for each case (Table 1) based on previously published SKY analysis (Bayani et al., Table W1 [4]), as well as the inclusion of three new specimens from two patients. SKY analysis of OCA27A/B revealed similar tetraploid karyotypes between the primary and metastatic tumors with complex aberrations. The composite karyotype for both OCA27A/B is summarized in Table W2 . In the case of OCA714, SKY revealed a highly rearranged karyotype, where almost every chromosome was involved in a complex aberration (Table W2 and Figure 1C ). Numerous complex translocations involved more than three different chromosomes and showed an extremely high number of breakpoints (n = 83) (Table 1, Figure 1C ) against a diploid background.
The enumeration of the number of clonal aberrations and breakpoints showed that diploid and near-diploid tumors possessed elevated DNA breakage events resulting in complex translocations, inversions, and deletions than whole chromosomal gains and losses (Table 1, Figure 3 , and see Bayani et al., Table W1 [4]). Nondiploid tumors, however, showed fewer incidences of clonal DNA breakage specimen and the number of analyzable metaphases, a precise enumeration of the total number of nonclonal rearrangements could not be accurately assessed.
Multicentric Chromosomes
The presence of chromosomal aberrations such as multicentric chromosomes, are additional hallmarks for genomic instability mediated by bridge-fusion-breakage events or critical telomere shortening [25, 26] . Thus, to determine whether these structures were present in these tumors, FISH using pan-centromeric PNA probes was performed and revealed the presence of dicentric chromosomes or ring chromosomes containing multiple pan-centromeric sequences as both clonal and nonclonal changes. Of the tumors analyzed, OCA8 was the only tumor that did not show evidence of multicentric chromosomes. The configurations of multicentromeric chromosomes varied and were identified as ring chromosomes as in the case of OCA5, telomeric fusions as detected in OCA714 as well as more typical dicentric configurations as in OCA21B and OCA27B ( Figure 1D ).
Centrosome Aberrations and Association with Increasing (N)-CIN
The percentage of cells with an aberrant centrosome was evaluated in all the specimens by fluorescent immunohistochemistry using anti-γ-tubulin ( Table 1 ). The most abnormal specimen was OCA5 with 24% of cells showing abnormal centrosome configuration or number ( Figure 1A) . The corresponding instability for this case, as previously discussed, was also the highest. Although mitotic figures were not frequent, abnormal mitoses were detected and shown in Figure 1B for OCA 27B. OCA3 and OCA27A/B also exhibited frequent centrosome aberrations (Table 1) Whereas the observed range of cells containing centrosomal aberrations was between 5.5% to 24.0% across all cases, increasing (N)-CIN indices were generally associated with the increasing frequency of cells with aberrant centrosomes as summarized in Figure 3 . One case, which failed to follow the general trend, was OCA714, where the relative (N)-CIN was low (7.0), although the incidence of centrosome abnormalities (20%) was high.
Discussion
The karyotypes of ovarian carcinomas are characterized by aneuploidy and structurally complex chromosomal rearrangements [1] [2] [3] [4] . Chromosomal instability (CIN) has traditionally been assessed by the rate of whole chromosomal copy number changes [9] , typically by interphase FISH analysis using centromere-specific probes. With the exception of a few recent studies [7, 10, 27] , the potential significance and extent of structural changes have been cursory. In this study, we investigated the relationship between the observed karyotypic complexity and ploidy changes observed by structural instability [(S)-CIN] and copy number-driven chromosomal instability [(N)-CIN], respectively, with features associated with aberrant mitotic progression in untreated sporadic ovarian carcinomas.
The interphase FISH study and the establishment of (N)-CIN indices revealed two distinct groups: Group 1 possessed a low range of (N)-CIN scores (7.0 to 21.0) characterized as near-diploid, and group 2 possessed a higher range of (N)-CIN scores (24.0 to 54.9), which were characterized by near-triploid and near-tetraploid karyotypes. The trend observed by the (N)-CIN indices was also seen, although more subtly, when the enumeration of abnormal centrosomes was assigned to each case. The increasing frequencies of cells with abnormal centrosomes were observed to be associated with the progression from a 2n cell complement to 2n±, then to 4n and 4n±, through to 3n± (Figure 3 ). The apparent transition to the tetraploidization event and subsequent reduction to pseudo-tetraploidy and (near) triploidy implicates errors in chromosomal segregation and cytokinesis. This is in keeping with centrosome studies showing the increased occurrence of mitotic segregation anomalies associated with centrosome amplification [28, 29] . However, the presence of centrosome amplification does not always commit cells to multipolarity [30] , because centrosome coalescent functions may still remain intact resulting in normal bipolar division [20, 31] . This may explain the findings of increased centrosome number in some diploid tumors, but showing relatively low-level (N)-CIN. In this situation, the presence of aberrant centrosome number or shape/configuration may simply be an early indicator of a general dysregulation of mitotic pathways. Unlike aneuploid genomes (i.e., 3n±, 4n±), which possess sufficient genomic material to survive the losses of several whole chromosomes through missegregation and multipolarity; gross missegregation of a Figure 2 . As shown here and in Figure 2 , during the progression from 2n± to 4n± to 3n±, the (N)-CIN indices of the tumors tested increased (blue). When the (S)-CIN events were plotted, we observed more predominant (S)-CIN events in the diploid tumors (green) with lower (N)-CIN indices. Fewer structural events appear to occur in tetraploid and triploid cancers, whereas their (N)-CIN indices increase. A less prominent trend is seen for the frequency of supernumerary and abnormal centrosomes (red); however, the cells with more centrosomal alterations were those that were near-tetraploid and near-triploid. The bottom figure illustrates the interplay between numerical and structural changes as it relates to changes in ploidy. At initiation, the diploid genome undergoes DNA-damaging events resulting in the accumulation of structural rearrangements. Such rearrangements result in accompanying changes in gene expression, affecting all pathways including the cell cycle and mitosis. Early indicators of cell cycle and mitotic dysregulation can include centrosomal amplification and low-level chromosomal polysomy while maintaining overall diploidy (bipolar division) during tumor expansion. At some critical point during tumor progression, the failure of cytokinesis occurs, resulting in the doubling of the genome as well as centrosomes. This event provides the genomic content and mitotic machinery to undergo gross numerical changes yielding tumor genomes that can assume near-tetraploid or near-triploid content. Although gross numerical changes are occurring, structural events are ongoing and may again become the predominant genomic event once a stable ploidy level has been obtained. It can be predicted that another failed cytokinetic event can occur and the cycle repeated, because 6n± and 5n± tumors have been observed in many cancers.
This suggests that tumor cells exhibiting centrosomal amplification and maintaining centrosomal clustering functions, observed by bipolar division [or relatively low (N)-CIN], can be selectively targeted. When the extent of (S)-CIN was investigated through the enumeration of clonal breakpoints (resulting from translocations, inversions, deletions), we found diploid and near-diploid tumors (OCA 8, OCA 15A/B, OCA718) possessed more occurrences of chromosomal breakage (Table 1 ). In particular, OCA714 displayed the greatest number of chromosomal breakages (n = 83), amidst a diploid background (Table 1) . These results suggested significant errors in DNA repair occurred before gross changes in copy number. Although chromosome breakage events (clonal and nonclonal aberrations) were observed as an ongoing event in the nondiploid cases, we found many complex rearrangements occurring as duplicates in near-tetraploid or near-triploid cases, indicating these rearrangements occurred before the tetraploidization of the genome. The presence of nonclonal chromosomal rearrangements across all tumor specimens indicated that errors in DNA repair were an ongoing event in the evolution of the tumor genome; however, it was noted that the diploid and triploid tumors showed slightly more nonclonal changes that were generally more structurally complex. The presence of multicentric chromosomes in all cases except for OCA8 further supports the notion that impaired DNA repair is an early event. Studies have shown the presence of such structures are mediated by the bridge-fusion-breakage cycle, described as a cycle involving chromatid breaks and fusions triggered by dicentric and ring chromosome rupture during anaphase resolution [33] . This self-perpetuating process gives rise to amplifications (HSRs, ladder amplifications), complex chromosomal rearrangements, inverted repeats, interstitial deletions, and large duplications [34, 35] . The occurrence of telomere fusions in some cases also implicates telomere shortening as a mechanism for generating the observed genomic instability [36] and has been described by Gisselsson et al. [26, 37] . The most striking result of the (S)-CIN study was the finding of numerous DNA breakage events that were independent of copy number changes. The limitation of such analyses, however, is in the ability of obtaining sufficient metaphases that are analyzable from short-term primary cultures.
Interestingly, the analysis revealed paired (OCA15A/B) and primary/ metastatic (OCA21A/B and OCA27A/B) specimens showed similar (N)-CIN and (S)-CIN indices, suggesting the existence of a putative clonal progenitor. These observations demonstrate that analysis of recurrent and metastatic samples derived from the same patients can provide insightful illustrations of the adaptive potential of tumor genomes during disease progression and in response to treatment.
The molecular cytogenetic analysis of these tumors have revealed several aspects of (N)-CIN and (S)-CIN, namely, that 1) sporadic ovarian carcinomas can show a wide range of (N)-CIN; 2) increasing (N)-CIN and changes in ploidy were associated with the increased occurrence of centrosome aberrations; and 3) (S)-CIN occurs more frequently in the diploid stage of karyotypic evolution, implicating a more prominent role for impaired DNA repair pathways early in tumor progression. A reevaluation of our previous molecular cytogenetic data in primary osteosarcoma and cell lines [23, [38] [39] [40] has also shown this interplay between (N)-CIN and (S)-CIN (unpublished observations) and is recapitulated in current studies (Maire et al., submitted). Based on these findings, we suggest that both forms of chromosomal aberrations can arise dependently and/or independently of each other, with one form more prevalent than the other at different times within the evolution of the tumor genome (Figure 3) . Thus, a delicate balance between (N)-CIN and (S)-CIN processes will influence the observed levels of structural and numerical change in a tumor.
BRCA1 is strongly associated with ovarian cancer [41] and has been shown to act as a regulator of DNA damage, repair, and transcription, and likely has a role in maintaining genomic stability [42] . There is increasing evidence (reviewed by Deng [42] ) suggesting the (S)-CIN damage response function of BRCA1 can act through RB and p53. Interestingly, BRCA1 mouse models in breast cancer [43, 44] have demonstrated patterns of aneuploidy and centrosomal amplification similar to the (N)-CIN findings presented in this study. In keeping with these observations, Bae et al. [45] demonstrated a role for BRCA1 in regulating the expression of genes implicated in the mitotic spindle checkpoint, chromosome segregation, centrosome function, cytokinesis, and the progression into and through mitosis resulting in multinucleated cells and failed cytokinesis.
The concept of tumor ploidy as an indicator of disease aggression and progression in ovarian cancer has been previously studied primarily by flow or image cytometric analyses [46] [47] [48] . The general consensus of these studies has found that diploid tumors possess a more favorable response to treatment and survival over those that are aneuploid. The extensive use of high-throughput microarray analyses has shown the average genomic changes in these tumors include whole and partial chromosomal gains and losses as well as focal regions of amplification and deletion [5, 49, 50] . More recently, these regions of genomic imbalance have been linked to the differential expression of microRNAs now emerging as important regulators of protein expression [51] [52] [53] . However, although providing detailed information regarding the net copy-number imbalances, the drawback of net/bulk genomic-based analysis is the inference of the tumor ploidy and rearrangement status in the absence of any parallel interphase or metaphase analyses. This poses a limitation because there is increasing interest in the karyotypic heterogeneity of tumors as a measure of genome (in)stability, which is lost when such bulk-based experiments are performed (reviewed by Bayani et al. [14] ). Such bulk-based studies appear to ignore the potentially significant contributions of polyclonality, which is often considered the source of "noise" in array analyses and consequently filtered out statistically. Certainly, as an extreme example, it has been demonstrated that rare cell populations such as cancer stem cells have a profound and significant impact on disease recurrence and treatment resistance [54, 55] despite its relatively small population.
In summary, the results of our study have demonstrated both aspects of CIN, that is, copy number change and structural change, should be distinguished. Thus, we propose to differentiate between these two aspects of CIN: (N)-CIN, characterized by the rate of copy number changes, and (S)-CIN, characterized by the extent of structural change and complexity. Indeed we have shown the presence of (S)-CIN can occur independently of gross copy number or ploidy changes and that interphase FISH analysis, for copy-number enumeration, alone is not sufficient to classify a given specimen as chromosomally unstable. The significance of such a distinction lies in the mechanisms that mediate the observed changes, providing viable avenues for therapeutic intervention. 
